Kodiak Sciences shares soared over 150% at the opening bell after its drugs completed a key trial. The stock continued to rise, doubling in value as the new eye disease drug matched up with Eylea in a phase 3 trial. Additional reports indicated the stock gained 172% as Kodiak's drugs targeted Regeneron's Eylea. The company's stock price rose sharply toward $100 following strong phase 3 DAYBREAK trial data for wet AMD.
More Top Stories
Scientists find dinosaur feather in ancient droppings: Tyrannosaur meal revealed
Scientists have made an unusual discovery inside fossilised dinosaur droppings: a bird feather. These ancient...
Messi's Final Match Ends with a Legendary Free Kick
Lionel Messi scored his 76th career free kick goal for Inter Miami against the Columbus Crew. This match repre...
Aston Villa and Tottenham Hotspur clash in crucial Premier League encounter
Tottenham Hotspur and Aston Villa are set to square off in the Premier League. The men's match features severa...
AI Boom Could Trigger Global Recession, Reports Australian Financial Review
The Australian Financial Review published a trend report on Saturday, September 26, 2026. It reported the AI b...
Johnny Appleseed Day celebrations are here
The Johnny Appleseed Fall Festival is happening on October 11 at Ariel Foundation Park. It will include apple...
Sydney Roosters and Newcastle Knights Clash in 2026 NRL Grand Final
The 2026 NRL Grand Final will see the Sydney Roosters face the Knights. The match is set after the Roosters we...
Latest Update · Latest Update · Daily Digest · Community Report · News Roundup · News Roundup · Weekly Review · Weekly Review · Weekly Review · Latest Update · Daily Digest · Daily Digest · Weekly Review · Daily Digest · Weekly Review · Weekly Review · Weekly Review · Daily Digest · Local Briefing · Latest Update · News Roundup · Latest Update · Weekly Review · Weekly Review · Community Report · Community Report · Community Report · Daily Digest · Daily Digest · Latest Update · News Roundup · Community Report · Community Report · Weekly Review · Latest Update · News Roundup · Community Report · News Roundup · Community Report · News Roundup